<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10935250</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Wieser, H G</dc:author>
<dc:author>Burcet, J</dc:author>
<dc:author>Russi, A</dc:author>
<dc:description xml:lang="en">INTRODUCTION The surgery of epilepsy is expanding considerably all over the world. It is becoming a standard treatment in patients who are resistant to conventional medical treatment. DEVELOPMENT In this article we explain the methodology used by the authors and suggest concepts regarding the epileptogenous area. We also explain the procedures used in neuroimaging and neurophysiology studies. CONCLUSIONS Good methodology, such as that used by the authors, results in up to 65% of the patients in whom amygdalo-hippocampectomy is done becoming completely seizure-free. Amygdalo-campectomy is the most specific indication in mesolimbic temporal epilepsy, which is also the main indication for the surgery of epilepsy.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Jun 16-30 </dc:date>
<dc:title xml:lang="es">Indicaciones del tratamiento quir√∫rgico de la epilepsia.</dc:title>
<dc:title xml:lang="en">[Indications of the surgical treatment of epilepsy].</dc:title>
<dc:publisher>Revista de neurologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
